A day in the life of investor Christian Angermayer The Enhanced Games co-founder never drinks, takes a low-dose GLP-1 and needs a witch, dragon or werewolf to unwind Evening Standard · Oct 17
GLP-1 Drugs and Anorexia: How Telehealth Loopholes Are Endangering the Most Vulnerable Patients Telehealth platforms are prescribing GLP-1 weight-loss drugs to patients with anorexia with little oversight — and the consequences are proving fatal. Latin Times · Oct 17
Women with PCOS Are Trying GLP-1 Drugs to Get Pregnant, but Fertility Evidence Is Still Early and Limited Some women with PCOS hope GLP-1 drugs will help them conceive. Here is what early studies show, when to stop the drugs, and what to ask a doctor first. Medical Daily · Oct 16
Walmart Makes Ozempic and Mounjaro Free for Workers with Type 2 Diabetes in 2027, Excluding Weight Loss Use Walmart will make Ozempic and Mounjaro free in 2027 for workers with Type 2 diabetes who get prior approval. Use for weight loss alone is not covered. Medical Daily · Oct 15
Weight Came Up in Only 39% of Recorded Diabetes Visits, and Bariatric Surgery Was Never Discussed at All Weight came up in 39% of recorded diabetes visits, and surgery never did. Questions people with type 2 diabetes can bring to their next appointment. Medical Daily · Oct 15
Roche Bets Up to $1.16 Billion on Rona's Obesity Drug That Aims to Cut Fat but Spare Muscle Roche licensed Rona's experimental ALK7 obesity drug in a deal worth up to $1.16 billion. No human data are out yet. What it means for weight loss. Medical Daily · Oct 15
GLP-1 Drugs Now Start as Low as $149 — But There’s a Catch For Americans who have been priced out of popular weight-loss medications, a $149 monthly price tag sounds like welcome news. After years of seeing drugs... Saving Advice · Oct 14
How weight loss drugs have been linked to surprising hair and nail problems IN FULL The Independent UK · Oct 13
Weight loss jabs linked to unusual health problem in new study Experts say potential side effects no reason to stop using jabs The Independent UK · Oct 13
GLP-1 Drugs Linked to 73% Fewer Bleeding Hospitalizations in Angiodysplasia Patients in Early, Unpublished ACG Meeting Data GLP-1 drugs were linked to 73% fewer GI bleeding hospitalizations in angiodysplasia patients in early ACG data. What it does and does not prove. Medical Daily · Oct 13
GLP-1 Users with Diabetic Retinopathy Had Less Macular Edema Than Metformin Users by Year Seven in Unreviewed Data An unreviewed AAO 2026 poster linked GLP-1 drugs to less diabetic macular edema than metformin over seven years. The gap was absent at one year. Medical Daily · Oct 12
Crumbl Faces 'Fading Novelty' and GLP-1 Snack Shifts as Sales Fall and Store Closures Mount in 2026 Crumbl has closed at least 57 US stores in 2026, while falling foot traffic, weaker sales, GLP-1 drugs and franchisee bankruptcy add to pressure on the cookie chain. International Business Times UK · Oct 11
What a desert lizard teaches us about patents and the GLP-1 revolution The GLP-1 story shows how patents can reward discovery and push rivals to develop better drugs. Fortune · Oct 10